-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Oncolytics Biotech (ONCY)
-
-
-
-
-
-
-
Oncolytics Biotech files patent application to extend pelareorep protection
-
-
-
-
-
-
-
Oncolytics Biotech outlines three-arm pancreatic cancer trial design
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Oncolytics Biotech (ONCY)
-
-
-
-
-
-
-
Regulatory Approval Clears Path for Oncolytics Biotech (ONCY) to Advance Promising Pancreatic Cancer Treatment, Following a Review of Safety Data
-
-
-
-
-
-
-
Oncolytics Biotech (ONCY) Reports In-Line Q2 EPS
-
-
432,916 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

